PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.

Heimbach T, Musuamba Tshinanu F, Raines K, Borges L, Kijima S, Malamatari M, Moody R, Veerasingham S, Seo P, Turner D, Fang L, Stillhart C, Bransford P, Ren X, Patel N, Sperry D, Chen H, Rostami-Hodjegan A, Lukacova V, Sun D, Nguefack JF, Carducci T, Grimstein M, Pepin X, Jamei M, Stamatopoulos K, Li M, Sanghavi M, Tannergren C, Mandula H, Zhao Z, Ju TR, Wagner C, Arora S, Wang M, Rullo G, Mitra A, Kollipara S, Chirumamilla SK, Polli JE, Mackie C

Open source

DOI
10.1021/acs.molpharmaceut.4c00758
Published
2024 Nov 4
Container
Molecular pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.molpharmaceut.4c00758,
  title = {PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.},
  author = {Heimbach T and Musuamba Tshinanu F and Raines K and Borges L and Kijima S and Malamatari M and Moody R and Veerasingham S and Seo P and Turner D and Fang L and Stillhart C and Bransford P and Ren X and Patel N and Sperry D and Chen H and Rostami-Hodjegan A and Lukacova V and Sun D and Nguefack JF and Carducci T and Grimstein M and Pepin X and Jamei M and Stamatopoulos K and Li M and Sanghavi M and Tannergren C and Mandula H and Zhao Z and Ju TR and Wagner C and Arora S and Wang M and Rullo G and Mitra A and Kollipara S and Chirumamilla SK and Polli JE and Mackie C},
  year = {2024},
  journal = {Molecular pharmaceutics},
  doi = {10.1021/acs.molpharmaceut.4c00758},
  url = {https://doi.org/10.1021/acs.molpharmaceut.4c00758}
}

RIS

TY  - JOUR
TI  - PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.
AU  - Heimbach T
AU  - Musuamba Tshinanu F
AU  - Raines K
AU  - Borges L
AU  - Kijima S
AU  - Malamatari M
AU  - Moody R
AU  - Veerasingham S
AU  - Seo P
AU  - Turner D
AU  - Fang L
AU  - Stillhart C
AU  - Bransford P
AU  - Ren X
AU  - Patel N
AU  - Sperry D
AU  - Chen H
AU  - Rostami-Hodjegan A
AU  - Lukacova V
AU  - Sun D
AU  - Nguefack JF
AU  - Carducci T
AU  - Grimstein M
AU  - Pepin X
AU  - Jamei M
AU  - Stamatopoulos K
AU  - Li M
AU  - Sanghavi M
AU  - Tannergren C
AU  - Mandula H
AU  - Zhao Z
AU  - Ju TR
AU  - Wagner C
AU  - Arora S
AU  - Wang M
AU  - Rullo G
AU  - Mitra A
AU  - Kollipara S
AU  - Chirumamilla SK
AU  - Polli JE
AU  - Mackie C
PY  - 2024
JO  - Molecular pharmaceutics
DO  - 10.1021/acs.molpharmaceut.4c00758
UR  - https://doi.org/10.1021/acs.molpharmaceut.4c00758
ER  - 

APA

T, H., F, M. T., K, R., L, B., S, K., M, M., R, M., S, V., P, S., D, T., L, F., C, S., P, B., X, R., N, P., D, S., H, C., A, R., V, L., D, S., JF, N., T, C., M, G., X, P., M, J., K, S., M, L., M, S., C, T., H, M., Z, Z., TR, J., C, W., S, A., M, W., G, R., A, M., S, K., SK, C., JE, P., & C, M. (2024). PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.. Molecular pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00758

Source records